<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>41(5)</volume><submitter>Tan VH</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Remote monitoring (RM) is crucial in managing patients with cardiac implantable electronic devices (CIED), and has been reported to improve clinical outcomes. The study's objective is to investigate whether compliance to RM has affected patients' long-term clinical outcomes.&lt;h4>Methods&lt;/h4>This was a prospective single-center cohort study of consecutive patients on RM with an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator followed up from 2018 to 2024. For analysis, patients were stratified according to whether they were compliant with RM. Compliance was defined as having ≥ 2 scheduled transmissions per year. Outcomes studied were the combined endpoints of all-cause mortality or heart failure hospitalization.&lt;h4>Results&lt;/h4>We a</pubmed_abstract><journal>Journal of arrhythmia</journal><pagination>e70203</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12507724</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical Outcomes on Remote Monitoring Compliance in Patients With Implantable Cardioverter Defibrillator.</pubmed_title><pmcid>PMC12507724</pmcid><pubmed_authors>Tan VH</pubmed_authors><pubmed_authors>Yeo C</pubmed_authors><pubmed_authors>Syed Hamid S</pubmed_authors><pubmed_authors>Mok XRJ</pubmed_authors><pubmed_authors>See Tow HX</pubmed_authors><pubmed_authors>Fong KY</pubmed_authors><pubmed_authors>Him AL</pubmed_authors><pubmed_authors>Lee LL</pubmed_authors><pubmed_authors>Ching CK</pubmed_authors><pubmed_authors>Koh XH</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical Outcomes on Remote Monitoring Compliance in Patients With Implantable Cardioverter Defibrillator.</name><description>&lt;h4>Background&lt;/h4>Remote monitoring (RM) is crucial in managing patients with cardiac implantable electronic devices (CIED), and has been reported to improve clinical outcomes. The study's objective is to investigate whether compliance to RM has affected patients' long-term clinical outcomes.&lt;h4>Methods&lt;/h4>This was a prospective single-center cohort study of consecutive patients on RM with an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator followed up from 2018 to 2024. For analysis, patients were stratified according to whether they were compliant with RM. Compliance was defined as having ≥ 2 scheduled transmissions per year. Outcomes studied were the combined endpoints of all-cause mortality or heart failure hospitalization.&lt;h4>Results&lt;/h4>We a</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T10:14:19.296Z</modification><creation>2026-05-08T03:10:39.485Z</creation></dates><accession>S-EPMC12507724</accession><cross_references><pubmed>41080219</pubmed><doi>10.1002/joa3.70203</doi></cross_references></HashMap>